Acadia EVP, General Counsel Austin Kim departs; transition period

ACADIA PHARMACEUTICALS INC

Austin D. Kim, Executive VP, General Counsel & Secretary, leaves Acadia to pursue other opportunities.
Mr. Kim will remain a non-executive employee during a transition period to assist with orderly handover.
No successor has been named as of the announcement date (January 30, 2024).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Austin D. Kim

Executive Vice President, General Counsel and Secretary

ACAD · ACADIA PHARMACEUTICALS INC

Filed: January 31, 2024, 6:59 PM ET

On January 30, 2024, Acadia Pharmaceuticals Inc. (the “Company”) announced that Austin D. Kim, Executive Vice President, General Counsel and Secretary, will be leaving the Company to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Austin D. Kim resigned as Executive Vice President, General Counsel and Secretary at ACADIA PHARMACEUTICALS INC.

Action: resigned
Role: Executive Vice President, General Counsel and Secretary

Exact text from the filing

On January 30, 2024, Acadia Pharmaceuticals Inc. (the “Company”) announced that Austin D. Kim, Executive Vice President, General Counsel and Secretary, will be leaving the Company to pursue other opportunities.

View on SEC.gov

ACADIA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001193125-24-019903

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.